Target intelligence / Profile preview

Uropathogenic Escherichia coli bacterial membrane lipids (UPEC membrane lipids)

Target
UPEC membrane lipids
Molecular classification
Lipid, Bacterial cell envelope component
01

Overview

Uropathogenic Escherichia coli (UPEC) bacterial membrane lipids are fundamental components of the bacterial cell envelope, comprising the inner cytoplasmic membrane and the outer membrane (OM). The OM is an asymmetric bilayer where the outer leaflet is primarily composed of lipopolysaccharides (LPS), while the inner leaflet contains phospholipids such as phosphatidylethanolamine and phosphatidylglycerol [1]. These lipids serve as a critical permeability barrier, protecting the bacterium from host immune defenses, such as antimicrobial peptides and bile salts, and are essential for the anchoring of virulence factors like fimbriae [2]. In the context of urinary tract infections (UTIs), UPEC lipids facilitate survival in the nutrient-poor and osmotically stressful environment of the bladder and kidneys [3]. Therapeutic strategies targeting these lipids often involve cationic antibiotics like polymyxins, which bind to the negatively charged Lipid A moiety of LPS, causing membrane destabilization and cell death [4]. However, the clinical utility of these drugs is constrained by nephrotoxicity and the potential for inducing septic shock through the massive release of endotoxins during bacterial lysis [5]. References: [1] Silhavy et al. (2010) Cold Spring Harb Perspect Biol; [2] Terlizzi et al. (2017) Front Microbiol; [3] Klein & Hultgren (2020) Nat Rev Microbiol; [4] Trimpa et al. (2022) Antibiotics; [5] Poirel et al. (2017) Clin Microbiol Rev.

Other names
UPEC cell envelope lipidsUPEC membrane componentsUropathogenic E. coli lipidsUPEC outer membrane lipids
02

Mechanism of action

Polymyxins and other cationic antimicrobial peptides interact electrostatically with the negatively charged phosphate groups of Lipid A in the outer membrane lipopolysaccharides, displacing stabilizing divalent cations and leading to membrane permeabilization and cell lysis [4].

03

Biological functions

Structural integrityPermeability barrierVirulence factor anchoringProtection against host immune systemIon homeostasis
04

Disease associations

InfectionUrinary tract infectionSepsis
05

Safety considerations

NephrotoxicityNeurotoxicityEndotoxin-induced systemic inflammatory response syndrome (SIRS)
06

Interacting drugs

Polymyxin B

2 more in the full profile.

07

Biomarkers

Lipid A modifications (e.g., addition of 4-amino-4-deoxy-L-arabinose)Circulating lipopolysaccharide (LPS) levels

Beyond the preview

Go deeper on Uropathogenic Escherichia coli bacterial membrane lipids (UPEC membrane lipids).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uropathogenic Escherichia coli bacterial membrane lipids (UPEC membrane lipids).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call